Gene ID | Gene Name ▼ | Gene Symbol | Disease Ontology |
---|---|---|---|
107548115 | transmembrane O-mannosyltransferase targeting cadherins 2a |
|
|
107580673 | transmembrane O-mannosyltransferase targeting cadherins 1 |
|
|
107590283 | tartrate-resistant acid phosphatase type 5-like |
|
|
107560649 | tartrate-resistant acid phosphatase type 5-like |
|
|
107598911 | sperm adhesion molecule 1 |
|
|
107574331 | sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase-like |
|
|
107587049 | ribitol xylosyltransferase 1 |
|
|
107551427 | rhodopsin, like |
|
|
107548743 | rhodopsin |
|
|
107559333 | ret proto-oncogene |
|
|
107554251 | putative polypeptide N-acetylgalactosaminyltransferase-like protein 3 |
|
|
107587232 | putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 |
|
|
107581920 | putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 |
|
|
107600015 | putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase |
|
|
107552584 | purinergic receptor P2X, ligand-gated ion channel, 5 |
|
|
107595680 | purinergic receptor P2X, ligand-gated ion channel, 4a |
|
|
107551435 | purinergic receptor P2X, ligand-gated ion channel, 3b |
|
|
107599138 | purinergic receptor P2X, ligand-gated ion channel, 2 |
|
|
107594797 | protein O-mannosyl-transferase 2-like |
|
|
107561547 | protein O-mannosyl-transferase 2-like |
|
|
107555474 | protein O-mannosyl-transferase 1-like |
|
|
107587516 | protein O-mannosyl-transferase 1-like |
|
|
107601673 | protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2-like |
|
|
107594636 | protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1-like |
|
|
107551215 | protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) |
|
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024